MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced financial results for the first quarter ended March 31, 2026, and ...

The 2026 represents our fourth full quarter of commercialization for ZUNVEYL. The first new oral Alzheimer's treatment approved in more than 15 years, and the quarter was a strong 1. We delivered 40% ...

With significant capital on the line, facilities demand a new lifecycle approach to risk that strengthens bankability, ...

A 2026 layered ATO defense playbook for online retailers: passkeys, adaptive MFA, device intel, behavioral biometrics, and incident response.

Bank of America Global Healthcare Conference 2026 May 14, 2026 12:20 PM EDTCompany ParticipantsLara Weber - CFO ...

Composition of matter provisional patent application filed for a new form of brilaroxazine designed to extend patent life and commercial exclusivity through 2046 - - FDA feedback on use of new form ...

Welcome to Valion Bio, Inc.'s conference call to discuss first quarter 2026 financial results. This call has been prerecorded. The call is being webcast, and the replay will be available on the ...

Fabio Capello is baffled as to why Milan can’t play like they did in the final 20 minutes of their recent 3-2 loss against ...

Operator: Greetings, and welcome to the PDS Biotech First Quarter 2026 Earnings Conference Call. [Operator Instructions] It ...

Global commerce has entered a phase where emerging markets play a decisive role in shaping demand, supply chains, and brand ...

SIM0505/CDH6 ADC dose optimization initiated in gynecologic cancersSIM0505 Phase 1 dose escalation study data to be presented at ASCO 2026 LNCB74 Phase 1 dose escalation trial update planned in second ...

The Indian stock market ended April 16 with minor losses; the Nifty 50 fell 0.14%. Sumeet Bagadia highlight the importance of resistance levels and suggest caution. Stocks like Neogen Chemicals and ...